In HCC, hsa-miR-195 suppressed cell proliferation and migration in vitro and in vivo by decreasing the expression of multiple NF-κB downstream effectors via direct targeting of IKKα and TAB3 [46]. This evidence concerns the gene CHUK and hepatocellular carcinoma.